ZIAC (nda020186)- (2.5MG;6.25MG,5MG;6.25MG,10MG;6.25MG)

Generic Name	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	Innovator	TEVA BRANDED PHARM
Dosage	2.5MG;6.25MG,5MG;6.25MG,10MG;6.25MG
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	2000-Sep-24	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	ZIAC (bisoprolol fumarate and hydrochlorothiazide) is indicated in the management of hypertension.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
7	0	6

Other Developers

Total Other Developers	15

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
2.5MG;6.25MG	**	**	-	5	1
5MG;6.25MG	**	**	-	-	6
10MG;6.25MG	**	**	-	-	6

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	5

Manufacturing Details of ZIAC